162 related articles for article (PubMed ID: 20686293)
1. Giant malignant insulinoma which developed from a non-functioning pancreatic tumor over a long period of time.
Sugiyama T; Kouyama R; Tani Y; Izumiyama H; Akashi T; Kishimoto S; Arii S; Hirata Y
Intern Med; 2010; 49(15):1573-9. PubMed ID: 20686293
[TBL] [Abstract][Full Text] [Related]
2. [Malignant insulinoma].
Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K
Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956
[TBL] [Abstract][Full Text] [Related]
3. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
[TBL] [Abstract][Full Text] [Related]
4. Giant pancreatic tumor with clinical characteristics of insulinoma but without common pathologic features.
Oberheim NA; Kim A; Farkas RL; Ruan DT; Schoeniger LO; Schiffhauer LM; Moalem J
Endocr Pract; 2011; 17(2):e12-6. PubMed ID: 21324828
[TBL] [Abstract][Full Text] [Related]
5. Malignant insulinoma misdiagnosed and treated as epilepsy.
Louda F; Chadli A; Elaziz S; Elghomari H; Farouqi A
Ann Endocrinol (Paris); 2013 Feb; 74(1):53-5. PubMed ID: 23351560
[TBL] [Abstract][Full Text] [Related]
6. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
[TBL] [Abstract][Full Text] [Related]
7. Insulinoma presenting as hypoglycemia during lactose tolerance testing: a case report.
Munro V; McDonell LM; Keough V; Siddiqi FS
J Med Case Rep; 2020 Jun; 14(1):96. PubMed ID: 32605595
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic localization of insulinoma. Experiences with 25 patients with solitary tumors].
Kisker O; Bastian D; Frank M; Rothmund M
Med Klin (Munich); 1996 Jun; 91(6):349-54. PubMed ID: 8767307
[TBL] [Abstract][Full Text] [Related]
9. A case of malignant insulinoma responsive to somatostatin analogs treatment.
Caliri M; Verdiani V; Mannucci E; Briganti V; Landoni L; Esposito A; Burato G; Rotella CM; Mannelli M; Peri A
BMC Endocr Disord; 2018 Dec; 18(1):98. PubMed ID: 30591061
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas.
Nakamura A; Mitsuhashi T; Takano Y; Miyoshi H; Kameda H; Nomoto H; Nagai S; Hatanaka Y; Shimizu C; Terauchi Y; Atsumi T
Endocr J; 2016; 63(2):135-42. PubMed ID: 26567922
[TBL] [Abstract][Full Text] [Related]
11. Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization.
Gorman B; Charboneau JW; James EM; Reading CC; Galiber AK; Grant CS; van Heerden JA; Telander RL; Service FJ
AJR Am J Roentgenol; 1986 Nov; 147(5):929-34. PubMed ID: 3020955
[TBL] [Abstract][Full Text] [Related]
12. Insulinoma Presenting with Neuropsychiatric Symptoms.
Aggarwal S; Nand N; Damle N; Godara R; Kumar R
J Assoc Physicians India; 2017 Jun; 65(6):95-96. PubMed ID: 28782321
[TBL] [Abstract][Full Text] [Related]
13. Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: a case report and review of the diagnostic strategies.
Christiansen E; Vestergaard H
Gynecol Endocrinol; 2008 Jul; 24(7):417-22. PubMed ID: 18645715
[TBL] [Abstract][Full Text] [Related]
14. Sporadic insulinoma in a 10-year-old boy: a case report and literature review.
Abu-Zaid A; Alghuneim LA; Metawee MT; Elkabbani RO; Almana H; Amin T; Azzam A
JOP; 2014 Jan; 15(1):53-7. PubMed ID: 24413786
[TBL] [Abstract][Full Text] [Related]
15. [Pancreatic insulinomas].
Miani S; Boneschi M; Erba M; Eusebio D; Giordanengo F
Minerva Chir; 1993 Dec; 48(23-24):1459-65. PubMed ID: 8177452
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.
Zimmer T; Stölzel U; Bäder M; Koppenhagen K; Hamm B; Buhr H; Riecken EO; Wiedenmann B
Gut; 1996 Oct; 39(4):562-8. PubMed ID: 8944566
[TBL] [Abstract][Full Text] [Related]
17. Insulinoma in tuberous sclerosis: An entity not to be missed.
Al Qahtani MS; Bojal SA; Alqarzaie AA; Alqahtani AA
Saudi Med J; 2021 Mar; 42(3):332-337. PubMed ID: 33632913
[TBL] [Abstract][Full Text] [Related]
18. [Insulinoma of the pancreas: analysis of a clinical series of 30 cases].
Andronesi D; Andronesi A; Tonea A; Andrei S; Herlea V; Lupescu I; Ionescu-Târgovişte C; Coculescu M; Fica S; Ionescu M; Gheorghe C; Popescu I
Chirurgia (Bucur); 2009; 104(6):675-85. PubMed ID: 20187465
[TBL] [Abstract][Full Text] [Related]
19. [An occult pancreatic insulinoma: radio-guided surgery with 111-In-octreotide. A case report and review of the literature on pre- and intraoperative diagnosis].
Ressetta G; Geatti O; Pozzetto B; Sustersich M; Povolato M; Ferretti G; Leggeri A
Ann Ital Chir; 2000; 71(1):107-12; discussion 113. PubMed ID: 10829532
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4.
Portela-Gomes GM; Stridsberg M; Grimelius L; Rorstad O; Janson ET
Endocr Pathol; 2007; 18(2):79-85. PubMed ID: 17916997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
